GT Biopharma

(NASDAQ) GTBP

Current Price$0.39

Market Cap$12.43M

Since IPO (1983)-100%

5 Year-100%

1 Year-82%

1 Month+2%

GT Biopharma Financials at a Glance

Market Cap

$12.43M

Revenue (TTM)

$0.00

Net Income (TTM)

$30.95M

EPS (TTM)

$-14.40

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$0.39

Volume

106,574

Open

$0.46

Price

$0.39

Volume

106,574

Open

$0.46

Previous Close

$0.39

Daily Range

$0.38 - $0.46

52-Week Range

$0.26 - $3.85

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$0.39

Volume

106,574

Open

$0.46

Previous Close

$0.39

Daily Range

$0.38 - $0.46

52-Week Range

$0.26 - $3.85

GTBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GT Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Michael Breen

Website

www.gtbiopharma.com

Headquarters

San Francisco, CA 94005, US

GTBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-1446%

Return on Capital

-2%

Return on Assets

-3%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

-0.74%

Stock Overview

Market Cap

$12.43M

Shares Outstanding

31.55M

Volume

106.57K

Avg. Volume

1.00M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$12.42M

EBITDA

$34.32M

Operating Cash Flow

$12.91M

Capital Expenditure

$0.00

Free Cash Flow

$12.91M

Cash & ST Invst.

$6.81M

Total Debt

$0.00

GT Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.43M

N/A

Market Cap/Employee

$12.43M

N/A

Employees

N/A

Net Income

$3.37M

-334.1%

EBITDA

$2.85M

-267.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.92M

+277.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-3.10%

N/A

Return on Invested Capital

-1.76%

N/A

Free Cash Flow

$2.47M

-12.1%

Operating Cash Flow

$2.47M

-12.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

ARTLArtelo Biosciences, Inc.

ARTLArtelo Biosciences, Inc.$1.84-21.37%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$0.98-4.92%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.65+51.10%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.19-3.25%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02-13.09%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.04-10.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About GTBP

What is the current price of GT Biopharma?

GT Biopharma is trading at $0.39 per share.

What is the 52-week range for GT Biopharma?

Over the past 52 weeks, GT Biopharma has traded between $0.26 and $3.85.

How much debt does GT Biopharma have?

As of the most recent reporting period, GT Biopharma reported total debt of N/A.

How much cash does GT Biopharma have on hand?

GT Biopharma reported $9.02M in cash and cash equivalents in its most recent financial results.

What is GT Biopharma’s dividend yield?

GT Biopharma does not currently have a dividend yield.

GT Biopharma

GT Biopharma Financials at a Glance

GTBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GT Biopharma

GTBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GT Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GTBP

What is the current price of GT Biopharma?

What is the 52-week range for GT Biopharma?

How much debt does GT Biopharma have?

How much cash does GT Biopharma have on hand?

What is GT Biopharma’s dividend yield?

Premium Investing Services